PBMs make more money when a drug's list price increases, while patients bear the financial burden.
Editor's note · Context
Menendez highlights the conflict of interest in PBM pricing structures.
Share & report
More from Bob Menendez
I thank my friend and colleague from Arizona for yielding and for his leadership on this issue. I rise today because while House Republicans vilify families that are coming to the United States for refuge, House Democrats and the Biden…
Adeel would make history as the first-ever Muslim to serve on our Federal appellate courts, a long overdue milestone in our efforts to diversify our Federal judiciary.
I could not be more proud of joining Senator Booker in recommending Adeel to President Biden for this important vacancy.
So is it also fair to say that since China is the economic force within that region that we are challenged in terms of our own national interests in meeting that economic force with one that can compete with it?





